Background: Endometriosis is a chronic, gynecological disorder, and the disease's pathogenesis is still debatable. Genes related to apoptosis have been revealed to be deregulated in endometriosis.
Objective: This study investigates the relationship between polymorphic variants of and -938C A promoter regions with endometriosis risk in an Iranian population.
Materials And Methods: In this case-control study, the polymorphisms of -248G A and -2 -938C A promoter regions were analyzed in 127 Iranian cases and 125 controls who were referred to Ali-ibn-Abi Taleb Educational hospital, Zahedan, Iran between May 2022 and February 2023. The genotypic analysis was performed for all the subjects using the polymerase chain reaction-restriction fragment length polymorphism method.
Results: The frequencies of mutant allele A carriers and the A allele of -248G A polymorphism showed about 2-fold significant increase of endometriosis risk (p = 0.04; p = 0.01, respectively). The frequencies of the mutant genotype AA and A allele carriers of -938C A polymorphism were approximately 4 and 2.5-fold higher in endometriosis compared to the control women, which were highly significant (p 0.001). Moreover, the allele A frequency of -938C A was associated with a 2-fold higher risk of endometriosis (p 0.001). Furthermore, the combination effects of these 2 single nucleotide polymorphisms showed that women with GGand AA variant alleles were associated with about 5 times higher risk of endometriosis (p 0.001). Notably, a significant difference was observed in mutant allele distribution between minimal/mild (stage I and II) and moderate/severe (stage III and IV) women with endometriosis disease.
Conclusion: The results of our study provide evidence that -938C A and -248G A single nucleotide polymorphisms might be associated with the risk of endometriosis.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11347765 | PMC |
| http://dx.doi.org/10.18502/ijrm.v22i6.16796 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Prevalence of endometriosis in women undergoing laparoscopic surgery for various gynecological indications: a Jordanian multi-center retrospective study.
BMC Womens Health
December 2024
Department of Physical Medicine and Rehabilitation,, Montefiore Medical Center, Bronx, NY, USA.
Background: Endometriosis, a condition that significantly impacts the quality of life for affected women, manifests with a spectrum of symptoms ranging from mild discomfort to severe pelvic pain, dysmenorrhea, dyspareunia, and infertility. A previous single-center study suggested an elevated prevalence of endometriosis in Jordan, prompting the need for larger studies to confirm these findings.
Methods: We conducted a cross-sectional study involving a sample of 866 women who underwent various laparoscopic procedures for different indications at the Department of Obstetrics and Gynecology at Jordan University Hospital and Al-Karak Governmental Hospital, two tertiary referral hospitals in Jordan between January 2015 and March 2023.
Living with acuteness in chronic illness: The temporal underpinnings of endometriosis.
Med Anthropol Q
December 2024
Helsinki Collegium for Advanced Studies, University of Helsinki, Helsinki, Finland.
This article explores how acuteness is experienced by people with endometriosis in Finland. Drawing on in-depth interviews as well as anonymous written endometriosis stories, we trace instances when the sense of chronicity and cyclicality of endometriosis is disrupted by a possibility of risk to life. These instances include when endometriosis tissue grows in unanticipated and aggressive ways, when medical interventions lead to unexpected complications or medications raise concerns about a gradually developing risk, and when endometriosis diagnosis becomes a catch-all category that could mask the onset of a life-threatening condition.
View Article and Find Full Text PDFUPDATE ON MEDICAL TREATMENT OF ENDOMETRIOSIS: NEW DRUGS OR NEW THERAPEUTIC APPROACHES?
Gynecol Obstet Invest
December 2024
Background: No conceptually new drugs for the safe and successful cure of endometriosis are likely to become available soon. Hormonal modulation of ovarian function and suppression of menstruation remain the pillars of disease control. However, existing drugs may be used following novel modalities to limit the consequences of endometriosis progression.
View Article and Find Full Text PDFPrevalence of irritable bowel syndrome in endometriosis patients: A cross-sectional study.
J Family Med Prim Care
November 2024
Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Background: Despite its prevalence, limited research has explored the direct correlation between irritable bowel syndrome (IBS) and endometriosis, particularly in regions like Saudi Arabia. This study aimed to bridge this gap by investigating the prevalence of IBS among endometriosis patients and identifying associated risk factors.
Materials And Methods: The study conducted a cross-sectional analysis, it was done at King Abdulaziz University Hospital, Jeddah.
Background: Current evidence on the role of macro- and micronutrients in the aetiopathogenesis of endometriosis is controversial.
Objectives: In this systematic review, we aimed to investigate the effect of macronutrients, dairy products, fruits, and vegetables on the occurrence and progression of endometriosis.
Materials And Methods: A systematic literature review of eligible articles retrieved from medical databases, including PubMed, Cochrane, and Academic Search, was performed from inception to May 2023.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!